Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New antibacterials for the treatment of toxoplasmosis; a patent review

1 Mar 2012

Abstract excerpt

INTRODUCTION: Toxoplasma gondii is an opportunistic protozoan parasite responsible for toxoplasmosis. T. gondii is able to infect a wide range of hosts, particularly humans and warm-blooded animals. Toxoplasmosis can be considered as one of the most prevalent parasitic diseases affecting close to one billion people worldwide, but its current chemotherapy is still deficient and is only effective in the acute phase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine and Purinergic Signaling
Share to Amoebic Infections and Treatments
Share to Toxoplasma gondii Research Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22404108
DOI: 10.1517/13543776.2012.668886

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New antibacterials for the treatment of toxoplasmosis; a patent reviewPMID 22404108Read ↗

Review of Experimental Compounds Demonstrating Anti-Toxoplasma ActivitySemantic proximity Read ↗

Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure–Activity Relationship InvestigationsSemantic proximity Read ↗

Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseasesSemantic proximity Read ↗

A Focused Small-Molecule Screen Identifies 14 Compounds with Distinct Effects on Toxoplasma gondiiSemantic proximity Read ↗

Metabolic interactions between Toxoplasma gondii and its hostSemantic proximity Read ↗

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read ↗

Dihydrofolate Reductase as a Target for Chemotherapy in ParasitesSemantic proximity Read ↗

Anti-Toxoplasma host defense systems and the parasitic counterdefense mechanismsSemantic proximity Read ↗

Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.Semantic proximity Read ↗

Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental modelsSemantic proximity Read ↗

Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of actionSemantic proximity Read ↗

A Brief Review of Drug Discovery Research for Human African TrypanosomiasisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.